Healthcare provider profile · identity verified

Carmen Rivera Perez, MD

General Practice · SAN JUAN, PR · NPI 1467400804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	328	59
Gabapentin	Gabapentin	211	38
Losartan Potassium	Losartan Potassium	198	37
Amlodipine Besylate	Amlodipine Besylate	167	31
Metformin Hcl	Metformin Hcl	163	26
Clonazepam	Clonazepam	106	13
Clopidogrel	Clopidogrel Bisulfate	98	17
Synthroid	Levothyroxine Sodium	89	17
Glipizide	Glipizide	85	15
Levothyroxine Sodium	Levothyroxine Sodium	80	15
Simvastatin	Simvastatin	80	18
Famotidine	Famotidine	78	19
Memantine Hcl	Memantine Hcl	75	12
Metoprolol Succinate	Metoprolol Succinate	71	18
Pantoprazole Sodium	Pantoprazole Sodium	69	20
Donepezil Hcl	Donepezil Hcl	67	12
Lantus	Insulin Glargine,hum.Rec.Anlog	66	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	64	16
Nabumetone	Nabumetone	63	11
Sertraline Hcl	Sertraline Hcl	63	14
Lisinopril	Lisinopril	62	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	suppressed
Furosemide	Furosemide	50	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	47	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	13
Tamsulosin Hcl	Tamsulosin Hcl	40	suppressed
Temazepam	Temazepam	39	suppressed
Diclofenac Potassium	Diclofenac Potassium	38	12
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	34	suppressed
Glimepiride	Glimepiride	33	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Baclofen	Baclofen	31	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Spironolactone	Spironolactone	31	suppressed
Mupirocin	Mupirocin	30	16
Atenolol	Atenolol	29	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Sucralfate	Sucralfate	27	suppressed
Glipizide Er	Glipizide	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Naproxen	Naproxen	21	suppressed
Jardiance	Empagliflozin	20	suppressed
Eliquis	Apixaban	19	suppressed
Latanoprost	Latanoprost	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Azithromycin	Azithromycin	17	16
Farxiga	Dapagliflozin Propanediol	17	suppressed
Humalog	Insulin Lispro	17	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Omeprazole	Omeprazole	15	suppressed
Cefadroxil	Cefadroxil	14	12
Cilostazol	Cilostazol	14	suppressed
Finasteride	Finasteride	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Lactulose	Lactulose	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error